RecruitingNot ApplicableNCT06775769

Endometrioma Sclerotherapy and Ovarian Preservation

Endometrioma Sclerotherapy and Ovarian Preservation: a Randomised Control Trial of Laparoscopic Sclerotherapy vs Traditional Excision of Endometrioma


Sponsor

Chelsea and Westminster NHS Foundation Trust

Enrollment

60 participants

Start Date

Feb 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

A randomised controlled trial assessing ovarian reserve after laparoscopic ethanol sclerotherapy of ovarian endometrioma compared to standard treatment of surgical excision of endometrioma. Secondary outcomes will include endometrioma recurrence, symptomatology and inflammatory environment.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Routine Care and a procedure called Sclerotherapy for people with endometrioma. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESclerotherapy

Laparoscopic ethanol sclerotherapy of endometrioma

PROCEDURERoutine Care

Routine surgical management of endometrioma


Locations(1)

Chelsea and Westminster NHS Foundation Trust

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06775769


Related Trials